The Global Institute for Novel Nicotine (GINN) is the leading industry voice for novel nicotine products. We advocate for and champion pouches, heat-not-burn, and other emerging reduced-risk products (RRPs) on behalf of our members.
"GINN embodies a commitment to shaping the future of reduced-risk nicotine, grounded in evidence, innovation, and collaborative industry leadership."
Shem Baldeosingh, Director
"The importance of bringing data to bear to ensure balanced decisions are made when it comes to regulations and policies that affect consumers cannot be overstated. This partnership with GINN underscores our commitment to scientific excellence and regulatory integrity."
Dr Bonnie Coffa, Chair of the Science and Standards Committee
“By partnering with GINN, Quartz Business Media aims to create more comprehensive and insightful experiences for our attendees, fostering greater understanding and innovation within the industry."
Tony Crinion, Managing Director of QBM
"We are excited to take on this leadership role with GINN and look forward to contributing to the advancement of science and standards within the nicotine industry. Our collective efforts will not only improve product safety but also ensure that regulatory policies are grounded in solid scientific evidence."
At the heart of GINN’s approach is our Science and Standards Committee (SSC). Chaired by an industry expert in toxicology and comprised of leading regulatory and scientific professionals familiar with nicotine, this committee is dedicated to developing detailed regulatory recommendations for the sector.
The Global Institute for Novel Nicotine (GINN) welcomes the important findings of a film by the BBC Morning Live programme on nicotine pouches which aired today on BBC One in the United Kingdom (UK). The programme highlighted the need for nicotine pouches to be sold as an age-gated product, given there are currently no laws […]
Inter Scientific, an independent contract research organisation and regulatory compliance firm, is pleased to announce its membership in the Global Institute for Novel Nicotine (GINN). GINN is dedicated to advancing tobacco harm reduction by supporting the research and development of smoke-free nicotine alternatives for adult smokers. The organisation promotes the highest regulatory compliance standards, focusing […]